ArticlePediatric transplantation2026
Metabolic Syndrome and Cardiovascular Outcomes in Pediatric Kidney Transplant Recipients-A Cross-Sectional Study.
Article in Pediatric transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe study aimed to determine the prevalence of obesity and metabolic syndrome (MS) and analyze the cardiovascular outcomes in pediatric kidney transplant recipients from a single center in India.
methodsDeterminants of MS, including weight, height, body mass index (BMI), blood pressure, fasting blood sugar, triglyceride, and high-density lipoprotein (HDL) were collected for children with at least 1 year follow-up post-transplant. Cardiovascular outcomes were hypertension, left ventricular hypertrophy (LVH), and carotid intima medial thickness (cIMT). Muscle strength was evaluated by measuring hand grip strength (HGS). Diagnosis of obesity and MS was done by applying recommendations from the Pediatric Renal Nutrition Task Force.
resultsThe median age of the cohort (32 recipients, 71% male) was 14.0 years (IQR 12.0, 15.9). At a median 21.5 months (IQR 17, 37.5) after first kidney transplantation, 9 (28.1%) had MS. Hypertriglyceridemia was present in 17 children (53.1%), low HDL cholesterol in 10 (31.2%), hypertension in 22 (68.8%), and fasting hyperglycemia in 7 (21.9%). The ΔBMI height-age Z-score was significantly higher in the MS group (p = 0.003). There was no difference in eGFR, LVMI, Triglyceride index and HGS between the MS and Non-MS groups. In multivariate regression analysis, the ΔBMI height-age Z-score and Acute rejection were independent predictors of MS and LVH, respectively. MS was not an independent predictor of LVH. All patients had elevated cIMT.
conclusionMS was found in about a third of the cohort. Graft function and LVH were similar between the groups. Post-transplant weight gain was a key determinant of MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.